Carrieri MP - Search Results

1

Impact of HAART-related side effects on unsafe sexual behaviours in HIV-infected injecting drug users: 7-year follow up.

Vincent E, Bouhnik AD, Carrieri MP, Rey D, Dujardin P, Granier F, Fuzibet JG, Obadia Y, Moatti JP, Spire B; MANIF-2000 Study Group. Vincent E, et al. Among authors: carrieri mp. AIDS. 2004 Jun 18;18(9):1321-5. doi: 10.1097/00002030-200406180-00011. AIDS. 2004. PMID: 15362665

2

Evaluation of buprenorphine maintenance treatment in a French cohort of HIV-infected injecting drug users.

Carrieri MP, Rey D, Loundou A, Lepeu G, Sobel A, Obadia Y; MANIF-2000 Study Group. Carrieri MP, et al. Drug Alcohol Depend. 2003 Oct 24;72(1):13-21. doi: 10.1016/s0376-8716(03)00189-3. Drug Alcohol Depend. 2003. PMID: 14563539

3

Physicians' knowledge and attitudes toward HIV care in the context of the UNAIDS/Ministry of Health Drug Access Initiative in Côte d'Ivoire.

Souville M, Msellati P, Carrieri MP, Brou H, Tape G, Dakoury G, Vidal L; Côte d'Ivoire HIV Drug Access Initiative Socio-Behavioural Evaluation Group. Souville M, et al. Among authors: carrieri mp. AIDS. 2003 Jul;17 Suppl 3:S79-86. doi: 10.1097/00002030-200317003-00011. AIDS. 2003. PMID: 14565613

4

Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: a 3-year follow-up study.

Carrieri MP, Raffi F, Lewden C, Sobel A, Michelet C, Cailleton V, Chêne G, Leport C, Moatti JP, Spire B; APROCO study group. Carrieri MP, et al. Antivir Ther. 2003 Dec;8(6):585-94. doi: 10.1177/135965350300800606. Antivir Ther. 2003. PMID: 14760892

5

Factors associated with liver biopsy performance in HCV-HIV coinfected injecting drug users with HCV viremia: results from a five-year longitudinal assessment.

Rey D, Carrieri MP, Spire B, Loubière S, Dellamonica P, Gallais H, Cassuto GP, Gastaut JA, Obadia Y; MANIF 2000 Study Group. Rey D, et al. Among authors: carrieri mp. J Urban Health. 2004 Mar;81(1):48-57. doi: 10.1093/jurban/jth087. J Urban Health. 2004. PMID: 15047783 Free PMC article.

6

Drug injection cessation among HIV-infected injecting drug users.

Bouhnik AD, Carrieri MP, Rey D, Spire B, Gastaut JA, Gallais H, Obadia Y; MANIF 2000 Study Group. Bouhnik AD, et al. Among authors: carrieri mp. Addict Behav. 2004 Aug;29(6):1189-97. doi: 10.1016/j.addbeh.2004.01.006. Addict Behav. 2004. PMID: 15236822

7

Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.

Bouhnik AD, Préau M, Vincent E, Carrieri MP, Gallais H, Lepeu G, Gastaut JA, Moatti JP, Spire B; MANIF 2000 Study Group. Bouhnik AD, et al. Among authors: carrieri mp. Antivir Ther. 2005;10(1):53-61. Antivir Ther. 2005. PMID: 15751763

8

Factors associated with nonadherence to highly active antiretroviral therapy: a 5-year follow-up analysis with correction for the bias induced by missing data in the treatment maintenance phase.

Carrieri MP, Leport C, Protopopescu C, Cassuto JP, Bouvet E, Peyramond D, Raffi F, Moatti JP, Chêne G, Spire B. Carrieri MP, et al. J Acquir Immune Defic Syndr. 2006 Apr 1;41(4):477-85. doi: 10.1097/01.qai.0000186364.27587.0e. J Acquir Immune Defic Syndr. 2006. PMID: 16652057

9

Access to HIV prophylaxis for survivors of sexual assault: the tip of the iceberg.

Carrieri MP, Bendiane MK, Moatti JP, Rey D. Carrieri MP, et al. Antivir Ther. 2006;11(3):391-2. Antivir Ther. 2006. PMID: 16759057

10

Protopopescu C, Marcellin F, Spire B, Préau M, Verdon R, Peyramond D, Raffi F, Chêne G, Leport C, Carrieri MP. Protopopescu C, et al. Among authors: carrieri mp. Qual Life Res. 2007 May;16(4):577-91. doi: 10.1007/s11136-006-9151-7. Epub 2007 Feb 1. Qual Life Res. 2007. PMID: 17268929

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

223 results

Search Page

Filters